logo
logo
Sign in

Cell Harvesting Market Future Scenarios and Business Growth Segment, Drivers, Trends, Forecast to 2027

avatar
apekshaagarwal
Cell Harvesting Market Future Scenarios and Business Growth Segment, Drivers, Trends, Forecast to 2027

Market Overview:

The cell harvesting market Share is expected to grow significantly over the forecast period. It is estimated that the cell harvesting market is expected to register a CAGR of Approx. 12.60% with an estimated market value of USD 9.8 Billion during the forecast period from 2020 to 2027. Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration.

Surge in the global transplantation rate along with the heightened demand for stem cell banking have also bolstered the need for cell harvesting worldwide. The latest sources of stem cells, like adipose tissue, embryonic stem cells and umbilical cord have remarkable potential for innovations in regenerative products and cancer treatment, which can possibly boost the market’s growth potential in the years ahead.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6801

Key Players:

Some of the key players in the global cell harvesting market are ads-tec GmbH, Avita Medical, Argos Technologies, Inc., Arthrex, Inc., Bertin, connectorate, Cox Scientific, hynoDent AG, PerkinElmer Inc., Scinomix, Teleflex Incorporated, and Terumo Corporation.

Regional Analysis:

The Americas and APAC or Asia Pacific coupled with MEA or Middle East and Africa and Europe are the major regions where the cell harvesting industry can witness growth in the coming years.

The Americas is the clear winner in the global market for cell harvesting, given that the region houses a well-established healthcare system with a high budget allocated for the same. Growing concerns regarding the dramatic rise in chronic diseases has raised the demand for cell harvesting in the region. The Center for Disease Control and Prevention reveals that in the year 2017, chronic disorders were the top reason for disability and death in the United States, with 133 million citizens or 45% of the total population suffering from at least one disease. Besides, the expanding population of elderly patients age and the surge in lifestyle-based ailments could be favorable for the cell harvesting industry in the region.

Europe is just behind Americas in the global market and has been scaling rapidly in view of the increased spending on research activities. Dramatic rise in heart disease, diabetes, spinal cord injuries and Parkinson's disease in the region has sharpened the focus on cell-based research and regenerative medicine. Also, the growth of the biotechnology sector over the years has been profitable for the regional market.

Asia Pacific can capture the fastest CAGR in the ensuing years, on account of the massive patient pool and the fast-emerging countries with developing healthcare systems. The APAC market for cell harvesting benefits from the rising number of deaths caused by hearth diseases and cancer, which in turn are escalating on the back of changing diets, sedentary lifestyles, consumption of tobacco and high obesity levels. The focus on exploring the potential of stem cells for the treatment of these diseases and more is deemed to be a key growth booster in the following years.

Segmentation:

The global cell harvesting market has been segmented into product type, application, and end user.

The market, based on product type, has been segmented into manual cell harvesters and automated cell harvesters.

The manual cell harvesters’ segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the automated cell harvesters’ segment is expected to be the fastest growing due to increased awareness and rise in the use of automated technologies in devices.

The market, by application, has been segmented into biopharmaceutical application, stem cell research, and others.

The market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.

The pharmaceutical company’s segment is estimated to account for the largest share. This owes to the increase in research and development activities of companies to come up with new innovative treatment options. The biotechnology companies’ segment is estimated to be the fastest growing due to the growing awareness about the advantages of using biotechnology techniques.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/cell-harvesting-market-6801

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

 

 

collect
0
avatar
apekshaagarwal
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more